23andMe Holding Co.

23andMe Holding Co. is a biotechnology company specializing in consumer genetics and research services. Founded in 2006 and headquartered in the San Francisco Bay Area, the company is a recognized innovator in helping individuals access, interpret, and act on information from their personal genome. Its core business encompasses two major segments: Consumer and Research Services, and Therapeutics. In Consumer and Research Services, 23andMe provides direct-to-consumer genetic testing kits that generate personalized reports on ancestry, genetic health risks, carrier status for inherited conditions, and traits. The company also operates a telehealth platform enabling access to affiliated healthcare professionals for consultation and treatment of common conditions. The Therapeutics segment leverages extensive genetic and phenotypic data to advance novel drug discovery programs, focusing on areas such as oncology, immunology, and inflammation, and participates in collaborations with pharmaceutical partners. 23andMe has played a transformative role in democratizing access to genetic information, fostering large-scale genetic research, and driving innovation at the intersection of consumer health and biotechnology.